The role played by 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] and/or by calcium on the C-25 hydroxylation of vitamin D3 (D3) was studied in hepatocytes isolated from D-depleted rats which were divided into four treatment groups: Group 1 served as controls, Group 2 received calcium gluconate, Groups 3 and 4 were infused with 1,25(OH)2D3 at 7 and 65 pmol/24 h x 7 days respectively. The treatments normalized serum calcium in all but the controls which remained hypocalcaemic, while serum 1,25(OH)2D3 remained low in Groups 1 and 2 but increased to physiologic and supraphysiologic levels in Groups 3 and 4. The data show that basal D3-25 hydroxylase activities were not significantly affected by any of the treatments. Addition of CaCl2, EGTA, or Quin-2 in vitro revealed that relative to basal values, EGTA strongly inhibited the enzyme activity in all groups (P < 0.0001), except in G 1; Quin-2 and CaCl2 had no significant effect on the activity of the enzyme in any of the groups. Addition of 1,25(OH)2D3 or A23187 in vitro in the presence of CaCl2 revealed that 1,25(OH)2D3 did not significantly affect enzyme activity, while A23187 was found to stimulate its activity in vitamin D-depleted animals, but most specifically in Group 2 (P < 0.001); low serum calcium (Group 1) dampened (P < 0.01), and 1,25(OH)2D3 treatment in vivo totally blunted (P < 0.001) the response to A23187. The data suggest that 1,25(OH)2D3 supplementation in vivo has per se little or no effect on the basal D3-25 hydroxylase activity. The data show, however, that the magnitude of the response to various challenges in vitro is greatly influenced by the conditioning in vivo of the animals. They also show that A23187 can be a potent stimulator of the enzyme activity, which allowed us to demonstrate a significant reserve for the C-25 hydroxylation of D3 which is well expressed in hepatocytes obtained from D-depleted calcium-supplemented rats.
INTRODUCTION
Vitamin D3 (D3), a natural secosteroid, has, in its native form, virtually no biological activity. The vitamin must undergo two hydroxylation reactions (at C-25 in the liver, and at C-la in the kidney) before acquiring its full biological potential. Although the regulation of the renal C-la hydroxylase has been the object of intensive studies, the factors involved in the regulation of the hepatic D3-25 hydroxylase have not yet been clearly defined. Among the most important unresolved questions concerning the hepatic C-25 hydroxylation of D3 are (1) the effect of previous dosing with D3 [1] [2] [3] ; (2) the effect of the vitamin D-hormone 1,25-dihydroxyvitamin D3 [1, 25(OH) 2D3] [4] [5] [6] ; as well as (3) the effect of the extraand/or intra-cellular calcium concentrations on the formation of the hepatic metabolite, 25-hydroxyvitamin D3 [25(0H)D3] [6, 7] .
Recent studies on the effect of 1,25(OH)2D3 on the D3-25 hydroxylase or on the fate of the hepatic or circulating 25(OH)D3 have either suggested that the hormone did not significantly affect the enzyme [8, 9] , that it inhibited the enzyme [4] [5] [6] 10] , or that it accelerated the metabolic clearance rate of 25(OH)D3 [11] , or increased the biliary excretion of 25(0H) [3H]D3-derived products [12] . Furthermore, other studies have also suggested that 1,25(OH)2D3 may also influence some hepatic metabolic patterns either directly or indirectly through its action on extracellular or intracellular calcium concentrations [13] [14] [15] [16] [17] .
The aim of the present studies was, therefore, to examine (1) [18] .
MATERIALS AND METHODS Animals and treatment procedures
The treatment procedures were as previously described [8] . Briefly, nursing female Sprague-Dawley rats with 14-day-old litters (Charles River, St. Constant, Quebec, Canada) were fed ad libitum a D-deficient diet [19] . At weaning, male rats were housed in hanging stainless-steel wire cages and fed a D-deficient diet as well as demineralized water for 6-8 wk before being randomly assigned to oral calcium- or homologous D-deficient rat plasma, saline (1:3:8:8, by vol.) was then added, and the media incubated at 37°C for 150 min in the presence of(1) Swim's 77 medium with no added calcium; (2) 2.5 mM-CaCl2 (1.9 mM-Ca2l); (3) 1 mM-EGTA; (4) 2,M-Quin-2 AM (Calbiochem, San Diego, CA, U.S.A.), (5) 100 pM-1,25(OH)2D3 in the presence of 1.9 mM-Ca2+; and (6) The incubation mixture was extracted with 15 ml ethyl acetate/toluene (9:1, v/v). Radioinert D3 (Sigma Chemical Co., St. Louis, MO, U.S.A.) (1 jug) and 25(OH)D3 (1 ,ug) were added as internal standards, and the final extraction mixture was vortexed with 0.4 g of ammonium carbonate. Following centrifugation, the organic phase was collected while the aqueous phase was extracted twice more using 10 ml of ethyl acetate/ methanol (9: 1, v/v). The combined organic phases were evaporated under a stream of N2.
The extracts were applied to Sephadex LH-20 columns and eluted with chloroform/n-hexane (19:31, Transformation of D3 into 25(OH)D3 in isolated hepatocytes: differences between groups Activity under basal conditions. Fig. 1 illustrates the basal activity (activity with no addition to the incubation media) of the D3-25 hydroxylase in hepatocytes isolated from animals in each of the four treatment groups. Results show that the overall activity of the enzyme did not appear to be significantly affected by any of the treatments in vivo.
Influence of CaC12, EGTA and of Quin-2. Table 2 presents the results obtained in the presence of CaC12, EGTA or Quin-2 in relation to results obtained under basal conditions. Addition of CaCl2 did not significantly affect the enzyme activity, with a mean increase of 10 % in hypocalcaemic rats, and mean decreases of 7 %, 17 % and 9 % in calcium-supplemented and the 7 and 65 pmol/day 1,25(OH)2D3-supplemented groups respectively [not significant (N.S.)]. Addition of EGTA to the incubation media, however, led to significant decreases in the overall enzyme activity compared with that obtained under basal conditions (P < 0.0001) with mean decreases of 16 % in hypocalcaemic rats (N.S.), 40.5 % in calcium-supplemented rats (P < 0.005), and 40.0% (P < 0.006) and 30.5 % (P < 0.05) in the 7 and 65 pmol/ day 1,25(OH)2D3-supplemented groups respectively. The effect of EGTA could be reversed by increasing amounts of CaC12. Addition of Quin-2 in the incubation media had no significant effect on the overall enzyme activity in Vol. 255 By contrast, addition of A23187 led to highly significant increases in the overall activity of the enzyme (P < 0.0002), as well as to significant differences between groups in the magnitude of the response (P < 0.0005). Further statistical analysis of the data using multiple comparisons between treatment means revealed that the D-depleted calcium-supplemented group, with a mean increase of 87 % over the activity observed in the presence of CaCl2 alone, is the group solely responsible for the overall statistically-significant increase in enzyme activity (P < 0.001), while 1,25(OH)2D3 treatment in vivo (P < 0.001) or low serum calcium concentrations (P < 0.01) blunted the response to A23187 compared with the value obtained in D-depleted normocalcaemic rats.
Rank order of potency of conditions in vitro on the transformation of D3 into 25(OH)D3: differences within groups Analysis of the rank order of potency of the various conditions in vitro indicated that the highest mean enzyme activity was obtained, in all treatment groups, in the presence of A23187, while the lowest mean enzyme activity was obtained, also in all treatment groups, in the presence of EGTA. The rank order of potency of the other compounds used varied from one group to another as illustrated in Table 4 . Within-group comparison showed that in the two D-depleted groups, A23187 led to significantly higher enzyme activity than for all other conditions except CaCl2 in hypocalcaemic rats where no significant difference between CaCl2 alone and CaCI2 + A23187 was found. In 1 ,25(OH)2D3-supplemented rats, EGTA led to lower enzyme activity than basal conditions, 1,25(OH)2D3, A23187, as well as Quin-2 in the 65 pmol/day group; in this group, CaCl2 also led to significantly lower enzyme activity than Quin-2 and A23187.
Influence of the circulating Ca2" and 1,25(OH)2D3 enzyme activity and the circulating serum calcium or 1,25(OH)2D3 concentrations were measured. Serum calcium concentrations were found to be only weakly inversely related to the value obtained in the presence of EGTA (r of -0.328, P < 0.1), while serum 1,25(OH)2D3 concentrations were inversely related to the values obtained in the presence of A23187 (r of -0.361, P < 0.05). No other correlation was found to be statistically significant.
DISCUSSION
The results obtained from the present studies show that vitamin D-depletion was achieved in all animals before the start of the treatment regimens, as indicated by the low serum calcium and 25(OH)D concentrations. The results also show that oral calcium gluconate was successful in normalizing total serum calcium concentrations without significantly changing the circulating 1,25(OH)2D3 concentrations. Administration of 1,25(OH)2D3 at doses of 7 and 65 pmol/24 h for 7 days also normalized serum calcium in both groups ofanimals. Moreover, despite circulation levels of the hormone far above normal in the group infused with the 65 pmol/ 24 h dose, serum calcium concentrations remained within the normal range, indicating that the hormone had no apparent toxic effect in these animals.
The results also indicate that the basal activity of the D3-25 hydroxylase remained unaltered by the treatment regimens used. This observation confirms results obtained in vivo, as well as in hepatic microsomal fractions from similarly treated rats [8] . The originality of the studies, however, resides in the observation that magnitude of response to various challenges in vitro was greatly influenced by the conditioning in vivo of the animals. Indeed, while the stimulatory or inhibitory effects of A23187 and EGTA respectively are quite clear in all groups, the magnitude of the response, not only to these two chemicals but also to all other compounds, was found to differ between groups. This observation suggests that subtle modulations in vivo of the enzyme and/or of its environment are able to lead to stimulated or blunted responses in the presence of these agents. The results obtained in the presence of A23187 and EGTA suggest that, in all groups, calcium is required for maximal enzyme activity.
The inhibitory effect of EGTA on the activity of the enzyme does not reveal whether its action was solely exerted through its chelating effect on extracellular calcium, or whether it was mediated via a drain on intracellular calcium reserves. Addition of CaCl2 alone to the incubation media did not, however, significantly stimulate the enzyme in any of the groups; this observation would tend to suggest that while extracellular calcium is needed for maximal enzyme activity, it does not seem to be the main determinant of its activity. On the one hand, the combined addition of CaCl2 and A23187 led to significant increases in enzyme activity in the D-depleted animals, but most particularly in the Ddepleted calcium-supplemented group. This suggests that upward spikes in intracellular cytosolic calcium and/or movements of calcium from an A23187-sensitive pool, such as the endoplasmic reticulum [25] which is the site of the physiologically responsive D3-25 hydroxylase [26, 27] , might be necessary to stimulate the enzyme when the latter is in optimum condition(s) to respond (i.e. in a state of D-depletion, and in the presence of sufficient ambient calcium). On the other hand, excessive amounts of calcium seem to decrease rather than increase the activity of the D3-25 hydroxylase as seen from the tendency of CaCl2 to increase enzyme activity in Ddepleted hypocalcaemic rats compared with the tendency to lower enzyme activity in all normocalcaemic animals, but most particularly in animals treated with 1 ,25(OH)2D3. The lack of effect of Quin-2 in most groups may be an indication that chelation of intracellular calcium resulting in a simple lowering of the resting cytosolic calcium is insufficient to affect enzyme activity, and that transient movements of intracellular calcium and/or calcium mobilization from external or internal sources are necessary to modulate enzyme activity.
The different response to 1,25(OH)2D3 addition in vitro in the D-depleted and the 1,25(OH)2D3-treated groups is also very interesting. Indeed, it has been reported that 1,25(OH)2D3 could act as a calcium ionophore in hepatocytes isolated from D-depleted rats [6] . However, contrary to the action of A23187, 1,25(OH)2D3 failed to increase significantly the activity of the enzyme in D-depleted animals, whereas in 1,25(OH)2D3-treated animals its action was similar to that obtained under basal conditions or in the presence of A23187. It is not impossible that the hormone acted as a competitor of D3 in D-depleted rats, leading then to a decrease in enzyme activity, and that administration of 1,25(OH)2D3 in vivo concealed further inhibition in vitro. Alternatively the intracellular calcium reserves, and thus the intracellular calcium-sensitive pool(s) may be different in D-depleted and 1,25(OH)2D3-treated rats, allowing different responses in the presence of agents able to mobilize calcium selectively from these pools. The situation may then be analogous to that for GH4C1 pituitary cells, where the endoplasmic reticulum has been shown to be insensitive to 1,25(OH)2D3 despite a 1,25(OH)2D3-enhanced intracellular calcium response to thyrotropin-releasing hormone [28] ; interestingly, in these cells, the action of 1,25(OH)2D3 was also blocked by EGTA. It is important to mention, however, that 1,25(OH)2D3 administration in vivo also leads to physiological and/or biochemical effects other than that of intracellular calcium mobilization [29] [30] [31] ; some of these effects may also be responsible for the difference in response in D-depleted and 1,25(OH)2D3-treated animals which was observed during our studies.
These studies show, for the first time, that only Ddepleted rats seem to have a significant hepatocytic reserve for the C-25 hydroxylation of D3. This reserve is uncovered by A23187 in animals treated with dietary calcium, but the response is dampened by calcium deprivation in vivo, and totally blunted by 1,25(OH)2D3 treatment. Based on the between-, as well as the withingroup differences in response to the other conditions studied in vitro, it is postulated that the cellular mechanism(s) involved in the failure to respond to A23 187 is (are) most likely different in hepatocytes obtained from D-depleted hypocalcaemic rats, and in hepatocytes obtained from 1,25(OH)2D3-treated animals.
